Skip to main content
NCBI home page
Gut logoLink to Gut
. 1972 Feb;13(2):128–137. doi: 10.1136/gut.13.2.128

Plasma protein turnover (albumin, transferrin, IgG, IgM) in Ménétrier's disease (giant hypertrophic gastritis): Evidence of non-selective protein loss 1

Stig Jarnum, Kurt Birger Jensen
PMCID: PMC1412056  PMID: 5045705

Abstract

Ten cases of Ménétrier's disease (`giant hypertrophic gastritis') have been studied with radioiodine-labelled albumin (all 10 cases), IgG (eight cases), transferrin (two cases), and IgM (six cases). Abnormal gastric loss of plasma protein was present in all cases as demonstrated by 59Fe-iron dextran (eight cases), 51Cr-albumin (one case), and 131I-polyvinylpyrrolidone (one case).

None of the patients had more distal gastrointestinal lesions. The synthetic rate of the proteins studied was normal or slightly elevated.

The fractional catabolic rate of the proteins was increased. The increase above the normal mean was similar for albumin, transferrin, and IgG. Since the molecular weight of IgG is more than twice that of albumin and transferrin, it is concluded that the protein loss in Ménétrier's disease is nonselective in the sense that it affects a similar fraction of the intravascular masses of all plasma proteins. IgM catabolism was strongly accelerated. Simultaneous studies with 50Fe-iron dextran, radioiodine-labelled albumin or IgG showed that IgM hypercatabolism could only partly be due to abnormal gastric protein loss, since IgM catabolism was significantly more raised than that of albumin and IgG. Faecal radioiodine excretion was normal in most patients after the injection of radioiodine-labelled proteins. It confirms a previous observation that increased gastrointestinal 59Fe clearance after injection of 59Fe-iron dextran associated with normal faecal radioiodine excretion after the injection of radioiodine-labelled proteins permits of a diagnosis of protein loss in the stomach.

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERSON S. A., YALOW R. S., SCHREIBER S. S., POST J. Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest. 1953 Aug;32(8):746–768. doi: 10.1172/JCI102789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CITRIN Y., STERLING K., HALSTED J. A. The mechanism of hypoproteinemia associated with giant hypertrophy of the gastric mucosa. N Engl J Med. 1957 Nov 7;257(19):906–912. doi: 10.1056/NEJM195711072571902. [DOI] [PubMed] [Google Scholar]
  3. GORDON R. S., Jr Exudative enteropathy: abnormal permeability of the gastrointestinal tract demonstrable with labelled polyvinylpyrrolidone. Lancet. 1959 Feb 14;1(7068):325–326. doi: 10.1016/s0140-6736(59)90309-5. [DOI] [PubMed] [Google Scholar]
  4. Jarnum S., Westergaard H., Yssing M., Jensen H. Quantitation of gastrointestinal protein loss by means of FE59-labeled iron dextran. Gastroenterology. 1968 Aug;55(2):229–241. [PubMed] [Google Scholar]
  5. Jensen H., Bro-Jorgensen K., Jarnum S., Olesen H., Yssing M. Transferrin metabolism in the nephrotic syndrome and in protein-losing gastroenteropathy. Scand J Clin Lab Invest. 1968;21(4):293–304. doi: 10.3109/00365516809076997. [DOI] [PubMed] [Google Scholar]
  6. Jensen K. B., Goltermann N., Jarnum S., Weeke B., Westergaard H. IgM turnover in Crohn's disease. Gut. 1970 Mar;11(3):223–228. doi: 10.1136/gut.11.3.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jensen K. B. Immunoglobulin M (IgM) turnover in hepatitis. Scand J Gastroenterol Suppl. 1970;7:33–37. [PubMed] [Google Scholar]
  8. Jensen K. B. Metabolism of human gamma-macroglobulin (IgM) in normal man. Scand J Clin Lab Invest. 1969 Oct;24(3):205–214. doi: 10.3109/00365516909080154. [DOI] [PubMed] [Google Scholar]
  9. KENNEY F. D., DOCKERTY M. B., WAUGH J. M. Giant hypertrophy of gastric mucosa; a clinical and pathological study. Cancer. 1954 Jul;7(4):671–681. doi: 10.1002/1097-0142(195407)7:4<671::aid-cncr2820070407>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  10. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  11. Overholt B. F., Jeffries G. H. Hypertrophic, hypersecretory protein-losing gastropathy. Gastroenterology. 1970 Jan;58(1):80–87. [PubMed] [Google Scholar]
  12. Waldmann T. A., Morell A. G., Wochner R. D., Strober W., Sternlieb I. Measurement of gastrointestinal protein loss using ceruloplasmin labeled with copper. J Clin Invest. 1967 Jan;46(1):10–20. doi: 10.1172/JCI105502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Waldmann T. A. Protein-losing enteropathy. Gastroenterology. 1966 Mar;50(3):422–443. [PubMed] [Google Scholar]
  14. Westergaard H., Jarnum S., Jensen H., Soltoft J., Yssing M. Topographic diagnosis of gastrointestinal protein loss. Digestion. 1968;1(6):341–352. doi: 10.1159/000196876. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES